Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-γ and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis

Clinical and Experimental Immunology

Volumn 160, Issue 3, 2010, Pages 380-385

  Leal, R F ^a   Ayrizono, M L S ^a   Milanski, M ^a   Coope, A ^a   Fagundes, J J ^a   Velloso, L A ^a   Coy, C S R ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytokines; Familial adenomatous polyposis; Ileal pouch; Pouchitis; Ulcerative colitis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; PROTEIN DERIVATIVE; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADENOMATOUS POLYP; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FAMILIAL POLYPOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM POUCH; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; MALE; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; ULCERATIVE COLITIS;

ADENOMATOUS POLYPOSIS COLI; ADULT; COLITIS, ULCERATIVE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; ILEUM; INTERFERON-GAMMA; INTERLEUKIN-10; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POUCHITIS; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 77952149348     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04088.x     Document Type: Article

References (47)

1. M'Koma AE. Serum biochemical evaluation of patients with functional pouches tem to 20 years after restorative proctocolectomy. Int J Colorectal Dis 2006 26 : 1 10.
2. Mc Guire BB, Brannigan AE, O'Connell PR. Ileal pouch-anal anastomosis. Br J Surg 2007 94 : 812 823.
3. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006 12 : S3 9.
4. Franke A, Balschun T, Karlsen TH et al. Sequence variants in IL-10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008 40 : 1319 1323.
5. McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut 2007 56 : 1333 1336. (Pubitemid 47517817)
6. Utsunomiya J, Iwama T, Imajo M et al. Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Dis Colon Rectum 1980 23 : 459 466. (Pubitemid 11216901)
7. Kiehne K, Brunke G, Wegner F et al. Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. World J Gastroenterol 2006 12 : 1056 1062.
8. Shen B, Fazio VW, Renzi FH et al. Risk factors for disease of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2006 4 : 81 9. (Pubitemid 43129516)
9. Meagher AP, Farouk R, Dozois RR et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998 85 : 800 803. (Pubitemid 28300513)
10. Laake KO, Bjorneklett A, Aamodt G et al. Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis. Scand J Gastroenterol 2005 40 : 43 51.
11. Ohge H, Furne JK, Springfield J et al. Association between fecal hydrogen sulfide production and pouchitis. Dis Colon Rectum 2005 48 : 469 475. (Pubitemid 40767867)
12. Kuehbacher T, Ott SJ, Helwig U et al. Bacterial and fungal microbiota in relation to probiotic therapy in pouchitis. Gut 2006 55 : 833 841. (Pubitemid 43764555)
13. Kienle P, Weitz J, Reinshagen S et al. Association of decreased perfusion of the ileoanal pouch mucosa with early postoperative pouchitis and local septic complications. Arch Surg 2001 136 : 1124 1130. (Pubitemid 32929338)
14. Heuschen G, Leowardi C, Hinz U et al. Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients. Int J Colorectal Dis 2007 22 : 293 301. (Pubitemid 46071107)
15. Sandborn WJ, Tremaine WJ, Batts KP et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994 69 : 409 415.
16. Shen B, Achkar JP, Connor JT et al. Modified Pouchitis Disease Activity Index. A simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003 46 : 748 753. (Pubitemid 36693394)
17. Akerlung JE, Lofberg R. Pouchitis. Curr Opin Gastroenterol 2004 20 : 341 344. (Pubitemid 38813675)
18. Lohmuller JL, Pemberton JH, Dozois RR et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990 211 : 622 629.
19. Hata K, Watanabe T, Shinozaki M et al. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003 38 : 1055 1058. (Pubitemid 37352469)
20. O'Shea J, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev 2002 2 : 37 45. (Pubitemid 37328774)
21. Mudter J, Weigmann B, Bartsch B et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel disease. Am J Gastroenterol 2005 100 : 64 72. (Pubitemid 41623270)
22. Schreiber S, Rosenstiel P, Hampe J et al. Activation of signal tranducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 2002 51 : 379 385.
23. Klampfer L, Huang J, Sasazuki T et al. Inhibition of interferon γ signaling by the short chain fatty acid butyrate. Mol Cancer Res 2003 1 : 855 862. (Pubitemid 37174457)
24. Gionchetti P, Campieri M, Belluzzi A et al. Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci 1994 39 : 1525 1531. (Pubitemid 2120471)
25. Evgenikos N, Bartolo DCC, Hamer-Hodges DW et al. Assessment of ileoanal pouch inflammation by interleukin 1β and interleukin 8 concentrations in the gut lumen. Dis Colon Rectum 2002 45 : 249 255. (Pubitemid 34141950)
26. Bulois P, Tremaine WJ, Maunoury V et al. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 2000 6 : 157 167.
27. Lammers KM, Vergopoulos A, Babel N et al. Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1β, interleukin-8 and interferon-γ gene expression. Inflamm Bowel Dis 2005 11 : 447 454. (Pubitemid 40704079)
28. Schmidt C, Giese T, Ludwig B et al. Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis 2006 21 : 419 426.
29. Helwig U, Gionchetti P, Rizello F et al. CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. Int J Colorectal Dis 2004 19 : 165 170. (Pubitemid 38239839)
30. Ulisse S, Gionchetti P, D'Aló S et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol 2001 96 : 2691 2699. (Pubitemid 32889207)
31. Kuhbacher T, Gionchetti P, Hampe J et al. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis. Clin Exp Immunol 2001 123 : 395 401. (Pubitemid 32289957)
32. Boerr L, Sambuelli A, Sugay E et al. Serum TGF-β1 and interferon-γ levels in ileal pouch-anal anastomosis in ulcerative colitis. Gastroenterology 1998 114 : A936 abstract
33. Schreiber S, Gionchetti P, Hampe J et al. Pouchitis shares similarities with ulcerative colitis in the pattern of cytokine transcription factor activation. Gastroenterology 1997 112 : A1086.
34. Stallmach A, Schafer F, Hoffmann S et al. Increased state of activation of CD4 positive T cells and elevated interferon γ production in pouchitis. Gut 1998 43 : 499 505. (Pubitemid 28462035)
35. Patel RT, Bain I, Youngs D et al. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995 38 : 831 837.
36. Góes JRN, Coy CSR, Amaral CA et al. Superior mesenteric artery syndrome as a complication of ileal pouch-anal anastomosis. Dis Colon Rectum 1995 38 : 543 544.
37. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 254.
38. Velloso LA, Folli F, Sun XJ et al. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 1996 93 : 12490 12495. (Pubitemid 26367171)
39. Araújo EP, De Souza CT, Gasparetti AL et al. Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistence, hyperinsulinemia, and increased adiposity. Endocrinology 2005 146 : 1428 1437.
40. Kuhbacher T, Schreiber S, Runkel N. Pouchitis: pathophysiology and treatment. Int J Colorectal Dis 1998 13 : 196 207. (Pubitemid 28554581)
41. Tulchinsky H, Hawley PR, Nicholls J. Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003 238 : 229 234. (Pubitemid 38174497)
42. Kuhn K, Lohler J, Rennick D et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993 75 : 263 274. (Pubitemid 23320290)
43. Leal RF, Coy CSR, Ayrizono MLS et al. Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in ileal pouches for ulcerative colitis and familial adenomatous polyposis. Tech Coloproctol 2008 12 : 33 8.
44. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor KB in inflammatory bowel disease. Gut 1998 42 : 477 484. (Pubitemid 28186562)
45. Wu F, Dassopoulos T, Cope L et al. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007 13 : 807 821. (Pubitemid 47203859)
46. Mudter J, Weigmann B, Bartsch B et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 2005 100 : 64 72. (Pubitemid 41623270)
47. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006 3 : 390 407. (Pubitemid 44018812)